The management is guiding for 11.3M in EBIT (top end of the range). Marketcap is AUD308M = US221M. They have 25M in cash, so EV is roughly 196M (221-25). That's EV/EBIT of 17x.
What's the tax rate? 30%?
That's 7.9M in Net Income or a PE of 28x. If you deduct the cash, PE is 25x.
On the call, Brad mentioned Signant Health and WCG as major competitors "who support standardized measures of cognition". What does he mean by that? Do those companies have similar tech?
CGS Price at posting:
$1.78 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)